Andreas D. Lauritzen

Andreas D. Lauritzen

Auto-generated profile, based on publicly available information

Andreas D. Lauritzen

Gentofte Hospital, Capital Region of Denmark

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Radiology
Verified
Journal Article
Closed access
ALAndreas D. Lauritzen
Andreas D. Lauritzen
ARAlejandro Rodríguez-Ruiz
Alejandro Rodríguez-Ruiz
MEMy Catarina von Euler-Chelpin
My Catarina von Euler-Chelpin
ELElsebeth Lynge
Elsebeth Lynge
IVIlse Vejborg
Ilse Vejborg
MLMartin Lillholm
Martin Lillholm
In a simulation study of breast cancer screenings in more than 114 000 women, an artificial intelligence–based mammography screening protocol had similar sensitivity to that of radiologist screenin... Background Developments in artificial intelligence (AI) systems to assist radiologists in reading mammograms could improve breast cancer screening efficiency. Purpose To investigate whether an AI s...

1 June 2024 in Radiology
Verified
Journal Article
Closed access
ALAndreas D. Lauritzen
Andreas D. Lauritzen
MLMartin Lillholm
Martin Lillholm
ELElsebeth Lynge
Elsebeth Lynge
MNMads Nielsen
Mads Nielsen
NKNico Karssemeijer
Nico Karssemeijer
IVIlse Vejborg
Ilse Vejborg
Full implementation of an artificial intelligence system considerably reduced the workload of breast radiologists while improving screening performance in a regional Danish population-based breast cancer screening program.

1 August 2023 in Radiology
Verified
Journal Article
Closed access
ALAndreas D. Lauritzen
Andreas D. Lauritzen
MEMy C. von Euler-Chelpin
My C. von Euler-Chelpin
ELElsebeth Lynge
Elsebeth Lynge
IVIlse Vejborg
Ilse Vejborg
MNMads Nielsen
Mads Nielsen
MLMartin Lillholm
Martin Lillholm
Background Recent mammography-based risk models can estimate short-term or long-term breast cancer risk, but whether risk assessment may improve by combining these models has not been evaluated. Purpose To determine whether breast cancer risk assessment improves when combining a diagnostic artificial intelligence (AI) system for lesion detection and a mammographic texture model. Materials and Methods This retrospective study included Danish women consecutively screened for breast cancer at mammography from November 2012 to December 2015 who had at least 5 years of follow-up data. Examinations were evaluated for short-term risk using a commercially available diagnostic AI system for lesion detection, which produced a score to indicate the probability of cancer. A mammographic texture model, trained on a separate data set, assessed textures associated with long-term cancer risk. Area under the receiver operating characteristic curve (AUC) analysis was used to evaluate both the individual and combined performance of the AI and texture models for the prediction of future cancers in women with a negative screening mammogram, including those with interval cancers diagnosed within 2 years of screening and long-term cancers diagnosed 2 years or more after screening. AUCs were compared using the DeLong test. Results The Danish screening cohort included 119 650 women (median age, 59 years [IQR, 53-64 years]), of whom 320 developed interval cancers and 1401 developed long-term cancers. The combination model achieved a higher AUC for interval and long-term cancers grouped together than either the diagnostic AI (AUC, 0.73 vs 0.70; P < .001) or the texture risk (AUC, 0.73 vs 0.66; P < .001) models. The 10% of women with the highest combined risk identified by the combination model accounted for 44.1% (141 of 320) of interval cancers and 33.7% (472 of 1401) of long-term cancers. Conclusion Combining a diagnostic AI system and mammographic texture model resulted in improved risk assessment for interval cancers and long-term cancers and enabled identification of women at high risk. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Poynton and Slanetz in this issue.

1 September 2023 in Journal of Medical Imaging
Verified
Journal Article
Closed access
PDF file
ALAndreas D. Lauritzen
Andreas D. Lauritzen
MEMy Catarina von Euler-Chelpin
My Catarina von Euler-Chelpin
ELElsebeth Lynge
Elsebeth Lynge
IVIlse Vejborg
Ilse Vejborg
MNMads Nielsen
Mads Nielsen
MLMartin Lillholm
Martin Lillholm
PurposeRisk-stratified breast cancer screening might improve early detection and efficiency without comprising quality. However, modern mammography-based risk models do not ensure adaptation across vendor-domains and rely on cancer precursors, associated with short-term risk, which might limit long-term risk assessment. We report a cross-vendor mammographic texture model for long-term risk.ApproachThe texture model was robustly trained using two systematically designed case-control datasets. Textural features, indicative of future breast cancer, were learned by excluding samples with diagnosed/potential malignancies from training. An augmentation-based domain adaption technique, based on flavorization of mammographic views, ensured generalization across vendor-domains. The model was validated in 66,607 consecutively screened Danish women with flavorized Siemens views and 25,706 Dutch women with Hologic-processed views. Performances were evaluated for interval cancers (IC) within 2 years from screening and long-term cancers (LTC) from 2 years after screening. The texture model was combined with established risk factors to flag 10% of women with the highest risk.ResultsIn Danish women, the texture model achieved an area under the receiver operating characteristic curve (AUC) of 0.71 and 0.65 for ICs and LTCs, respectively. In Dutch women with Hologic-processed views, the AUCs were not different from AUCs in Danish women with flavorized views. The AUC for texture combined with established risk factors increased to 0.68 for LTCs. The 10% of women flagged as high-risk accounted for 25.5% of ICs and 24.8% of LTCs.ConclusionsThe texture model robustly estimated long-term breast cancer risk while adapting to an unseen processed vendor-domain and identified a clinically relevant high-risk subgroup.

21 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
BVBolette Mikela Vilmun
Bolette Mikela Vilmun
GNGeorge Napolitano
George Napolitano
ALAndreas Lauritzen
Andreas Lauritzen
ELElsebeth Lynge
Elsebeth Lynge
MLMartin Lillholm
Martin Lillholm
IVIlse Vejborg
Ilse Vejborg
Assessing a woman’s risk of breast cancer is important for personalized screening. Mammographic density is a strong risk factor for breast cancer, but parenchymal texture patterns offer additional information which cannot be captured by density. We aimed to combine BI-RADS density score 4th Edition and a deep-learning-based texture score to stratify women in screening and compare rates among the combinations. This retrospective study cohort study included 216,564 women from a Danish populations-based screening program. Baseline mammograms were evaluated using BI-RADS density scores (1–4) and a deep-learning texture risk model, with scores categorized into four quartiles (1–4). The incidence rate ratio (IRR) for screen-detected, interval, and long-term cancer were adjusted for age, year of screening and screening clinic. Compared with subgroup B1-T1, the highest IRR for screen-detected cancer were within the T4 category (3.44 (95% CI: 2.43–4.82)−4.57 (95% CI: 3.66–5.76)). IRR for interval cancer was highest in the BI-RADS 4 category (95% CI: 5.36 (1.77–13.45)−16.94 (95% CI: 9.93–30.15)). IRR for long-term cancer increased both with increasing BI-RADS and increasing texture reaching 5.15 (4.31–6.16) for the combination of B4-T4 compared with B1-T1. Deep-learning-based texture analysis combined with BI-RADS density categories can reveal subgroups with increased rates beyond what density alone can ascertain, suggesting the potential of combining texture and density to improve risk stratification in breast cancer screening.

11 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
EJEspen Jimenez-Solem
Espen Jimenez-Solem
TPTonny Studsgaard Petersen
Tonny Studsgaard Petersen
CHCasper Hansen
Casper Hansen
CHChristian Hansen
Christian Hansen
CLChristina Lioma
Christina Lioma
MSMartin Sillesen
Martin Sillesen
Background: Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We hypothesized that Machine Learning (ML) models could be used to predict risks at different stages of management (at diagnosis, hospital admission and ICU admission) and thereby provide insights into drivers and prognostic markers of disease progression and death. Methods: From a cohort of approx. 2.6 million citizens in the two regions of Denmark, SARS-CoV-2 PCR tests were performed on subjects suspected for COVID-19 disease; 3944 cases had at least one positive test and were subjected to further analysis. A cohort of SARS- CoV-2 positive cases from the United Kingdom Biobank was used for external validation. Findings: The ML models predicted the risk of death (Receiver Operation Characteristics – Area Under the Curve, ROC-AUC) of 0.904 at diagnosis, 0.818, at hospital admission and 0.723 at Intensive Care Unit (ICU) admission. Similar metrics were achieved for predicted risks of hospital and ICU admission and use of mechanical ventilation. We identified some common risk factors, including age, body mass index (BMI) and hypertension as driving factors, although the top risk features shifted towards markers of shock and organ dysfunction in ICU patients. The external validation indicated fair predictive performance for mortality prediction, but suboptimal performance for predicting ICU admission. Interpretation: ML may be used to identify drivers of progression to more severe disease and for prognostication patients in patients with COVID-19. Prognostic features included age, BMI and hypertension, although markers of shock and organ dysfunction became more important in more severe cases. We provide access to an online risk calculator based on these findings. Funding: The study was funded by grants from the Novo Nordisk Foundation to MS (#NNF20SA0062879 and #NNF19OC0055183) and MN (#NNF20SA0062879). The foundation took no part in project design, data handling and manuscript preparation.